Jump to content

Clinical Advertisement
Sign in to follow this  
Health Reporter

Pubmed-Histamine-mediated potentiation of TRPA1 and TRPV4 signaling in submucosal neurons in IBS patients.

Recommended Posts

Health Reporter

Histamine-mediated potentiation of TRPA1 and TRPV4 signaling in submucosal neurons in IBS patients.

Am J Physiol Gastrointest Liver Physiol. 2019 Jan 10;:

Authors: Balemans D, Aguilera-Lizarraga J, Florens MV, Jain P, Denadai-Souza A, Viola MF, Aguiar Alpizar Y, Van Der Merwe S, Vanden Berghe P, Talavera K, Vanner SJ, Wouters MM, Boeckxstaens GE

Previously, we showed histamine-mediated sensitization of TRP vanilloid 1 (TRPV1) in patients with irritable bowel syndrome (IBS). Sensitization of TRP ankyrin 1 (TRPA1) and TRP vanilloid 4 (TRPV4) are also involved in aberrant pain perception in preclinical models of somatic pain. Here, we hypothesize that in parallel with TRPV1, histamine sensitizes TRPA1 and TRPV4, contributing to increased visceral pain in patients with IBS. Rectal biopsies were collected from IBS patients and healthy subjects (HS) to study neuronal sensitivity to TRPA1 and TRPV4 agonists (cinnamaldehyde and GSK1016790A) using intracellular Ca2+ imaging. In addition, the effect of supernatants of rectal biopsies on IBS patients and HS was assessed on TRPA1 and TRPV4 responses in murine dorsal root ganglia (DRG) sensory neurons. Finally, we evaluated the role of histamine and histamine 1 receptor (H1R) in TRPA1 and TRPV4 sensitization. Application of TRPA1 and TRPV4 agonists evoked significantly higher peak amplitudes and percentage of responding submucosal neurons in biopsies of IBS patients compared to HS. In HS, pretreatment with histamine significantly increased the Ca2+ responses to cinnamaldehyde and GSK1016790A, an effect prevented by H1R antagonism. IBS supernatants, but not of HS, sensitized TRPA1 and TRPV4 on DRG neurons. This effect was reproduced by histamine and prevented by H1R antagonism. We demonstrate that the mucosal microenvironment in IBS contains mediators, such as histamine, which sensitize TRPV4 and TRPA1 via H1R activation, most likely contributing to increased visceral pain perception in IBS. These data further underscore H1R antagonism as potential treatment for IBS.

PMID: 30629470 [PubMed - as supplied by publisher]

View the full article

Share this post

Link to post
Share on other sites
Sign in to follow this